The Path to Personalized Medicine
New England Journal of MedicinePublished 15 June 2010Open access
Margaret Hamburg, Francis S. Collins
Citations1,937
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The challenge is to deliver the benefits of this work to patients by developing and using diagnostic tests based on genetics or other molecular mechanisms to better predict patients' responses to targeted therapy.
Abstract
http://dx.doi.org/10.1056/NEJMp1006304
Keywords
Biochemistry, Genetics and Molecular BiologyEngineering
Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyPharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
306 Citations2008Felix W. Frueh, Shashi Amur +7 more
To review the labels of United States Food and Drug Administration‐approved drugs to identify those that contain pharmacogenomic biomarker information, and to collect prevalence information on the use of those drugs for which pharmacogenetic information is included in the drug labeling.